Finnrick Analytics
About
Independent testing and verification of product safety and authenticity to ensure a safer supply chain for peptides and supplements.
Medical Team
Michael Carter
Chairman
Raphaël Mazoyer
Business Lead
Stephanie Adamson King
Policy & Platforms
Services & Peptides Offered
Peptide Protocols Finnrick Specializes In
GLP-1 Agonists
Semaglutide, Tirzepatide
Mimics the GLP-1 hormone to regulate appetite, slow gastric emptying, and improve insulin sensitivity. Gold standard for sustainable weight loss.
BPC-157
Body Protection Compound-157
A pentadecapeptide derived from human gastric juice. Shown to promote angiogenesis, accelerate wound healing, and reduce inflammation in preclinical studies.
CJC-1295
GRF 1-29 + DAC
Growth hormone-releasing factor with a drug affinity complex (DAC) that extends half-life. Increases IGF-1 levels and supports lean body composition.
Ipamorelin
N,N-dimethyl-GHRP-2
A selective growth hormone secretagogue (GHS) that stimulates GH release with minimal cortisol side effects. Known for clean, targeted action.
Get Started
Details
Address
Austin, TX
Visit Type
In-Person Only
Insurance
Self-Pay / Cash Only
Website
finnrick.com
Licensed States
TX
Frequently Asked Questions
- Where is Finnrick Analytics located?
- Finnrick Analytics is located at Austin, TX.
- Does Finnrick Analytics accept insurance?
- Finnrick Analytics operates on a self-pay / cash-pay basis and does not accept insurance directly. They may provide superbills for out-of-network reimbursement.
- What peptides and services does Finnrick Analytics offer?
- Finnrick Analytics offers Semaglutide, Tirzepatide, BPC-157, CJC-1295, Ipamorelin, Retatrutide. Contact them for a full list of available treatments.
- Who are the providers at Finnrick Analytics?
- The medical team at Finnrick Analytics includes Michael Carter, Raphaël Mazoyer, Stephanie Adamson King.
Disclaimer: Peptide Injections AI is an informational and referral platform. Finnrick Analytics is an independent licensed healthcare provider. Services, pricing, and availability may vary. All treatment decisions should be made in consultation with a licensed provider in your state.